HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tianrui Yang Selected Research

rhuMAb-E25

4/2023Effectiveness and Safety Studies of Omalizumab in Children and Adolescents With Moderate-To-Severe Asthma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tianrui Yang Research Topics

Disease

6Neoplasms (Cancer)
03/2024 - 01/2021
5Glioma (Gliomas)
03/2024 - 01/2020
5Glioblastoma (Glioblastoma Multiforme)
01/2024 - 01/2021
2Asthma (Bronchial Asthma)
01/2024 - 04/2023
2Central Nervous System Neoplasms
01/2024 - 01/2023
2Thrombosis (Thrombus)
09/2023 - 05/2019
2Hemorrhage
09/2023 - 05/2019
2Heart Diseases (Heart Disease)
05/2021 - 01/2019
2Heart Failure
02/2020 - 06/2018
1Oligodendroglioma
01/2024
1Astrocytoma (Pilocytic Astrocytoma)
01/2024
1Stroke (Strokes)
09/2023
1Obesity
09/2023
1Atrial Fibrillation
09/2023
1COVID-19
01/2022
1Frailty
01/2022
1Breakthrough Infections
01/2022
1Drug-Related Side Effects and Adverse Reactions
10/2021
1Cardiovascular Diseases (Cardiovascular Disease)
05/2021
1Muscular Diseases (Myopathy)
05/2021
1Carcinogenesis
01/2021
1Venous Thromboembolism
05/2019
1Human Influenza (Influenza)
01/2019
1Atherosclerosis
01/2019
1Lung Neoplasms (Lung Cancer)
02/2018

Drug/Important Bio-Agent (IBA)

3Biomarkers (Surrogate Marker)IBA
01/2023 - 01/2020
2AnticoagulantsIBA
09/2023 - 05/2019
2Immune Checkpoint InhibitorsIBA
01/2022 - 01/2021
2VaccinesIBA
01/2022 - 01/2022
1Bevacizumab (Avastin)FDA Link
03/2024
1Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
01/2024
1Adenosine Monophosphate (AMP)IBA
01/2024
1RivaroxabanIBA
09/2023
1apixabanIBA
09/2023
1Nitric Oxide (Nitrogen Monoxide)FDA Link
04/2023
1anti-IgE antibodiesIBA
04/2023
1rhuMAb-E25IBA
04/2023
1Omalizumab (Xolair)FDA Link
04/2023
1Immunoglobulin E (IgE)IBA
04/2023
1A 7 (A-7)IBA
01/2023
1ValganciclovirFDA Link
09/2022
1mesoglycanIBA
01/2022
1Messenger RNA (mRNA)IBA
01/2022
1Acetaminophen (Paracetamol)FDA LinkGeneric
10/2021
1oxidized low density lipoproteinIBA
05/2021
18- hydroxy- 2,2,14,14- tetramethylpentadecanedioic acidIBA
05/2021
1LDL CholesterolIBA
05/2021
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
05/2021
1Temozolomide (Temodar)FDA LinkGeneric
01/2021
1Thyroid HormonesIBA
02/2020
1Thyroxine (Levothyroxine)FDA LinkGeneric
02/2020
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
05/2019
1baloxavirIBA
01/2019
1EndonucleasesIBA
01/2019
1Antiviral Agents (Antivirals)IBA
01/2019
1Long Noncoding RNAIBA
01/2019
1ginsenoside Rb1IBA
06/2018
1MicroRNAs (MicroRNA)IBA
02/2018
1Small Untranslated RNAIBA
02/2018

Therapy/Procedure

6Therapeutics
03/2024 - 05/2021
3Immunotherapy
01/2022 - 01/2021
1Aftercare (After-Treatment)
04/2023
1Radiotherapy
01/2022
1Palliative Care (Palliative Therapy)
01/2022
1Drug Therapy (Chemotherapy)
01/2022
1Chemoradiotherapy
01/2021
1Orthopedic Procedures
05/2019